NasdaqCM - Delayed Quote USD
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
7.38
-0.12
(-1.60%)
As of 9:30:46 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 9 | 9 |
| Avg. Estimate | -1.07 | -1.11 | -4.15 | -4.68 |
| Low Estimate | -1.3 | -1.29 | -5.28 | -6.31 |
| High Estimate | -0.87 | -0.92 | -2.36 | -3.14 |
| Year Ago EPS | -0.83 | -0.9 | -3.68 | -4.15 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 9 | 9 |
| Avg. Estimate | -- | -- | 1.11M | 4.11M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 10M | 25M |
| Year Ago Sales | -- | -- | -- | 1.11M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 270.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.09 | -1.19 | -0.95 | -1.26 |
| EPS Actual | -0.83 | -0.9 | -1.15 | -0.78 |
| Difference | 0.26 | 0.29 | -0.2 | 0.48 |
| Surprise % | 23.85% | 24.26% | -20.73% | 38.04% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.07 | -1.11 | -4.15 | -4.68 |
| 7 Days Ago | -1.51 | -1.59 | -5.68 | -5.58 |
| 30 Days Ago | -1.51 | -1.59 | -5.73 | -5.59 |
| 60 Days Ago | -1.51 | -1.59 | -5.73 | -5.59 |
| 90 Days Ago | -1.51 | -1.59 | -5.73 | -5.59 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 3 | 3 | 8 | 8 |
| Up Last 30 Days | 3 | 3 | 7 | 7 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CRBP | -29.26% | -22.86% | -12.80% | -12.69% |
| S&P 500 | 9.62% | 4.20% | 8.36% | 13.90% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/12/2025 |
| Maintains | Jefferies: Buy to Buy | 3/11/2025 |
| Initiated | William Blair: Outperform | 2/28/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/18/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/10/2025 |
| Initiated | Piper Sandler: Overweight | 12/2/2024 |
Related Tickers
JANX Janux Therapeutics, Inc.
32.07
-0.50%
RGNX REGENXBIO Inc.
9.03
-1.15%
TIL Instil Bio, Inc.
12.20
-1.93%
RPTX Repare Therapeutics Inc.
1.3400
-1.47%
ATXS Astria Therapeutics, Inc.
5.06
+2.02%
GPCR Structure Therapeutics Inc.
24.24
+2.62%
VERV Verve Therapeutics, Inc.
5.65
-1.40%
JAGX Jaguar Health, Inc.
11.83
+11.13%
VYNE VYNE Therapeutics Inc.
1.4400
+0.70%
CRDF Cardiff Oncology, Inc.
2.9200
-1.02%